Jefferies Reiterates Buy Rating on Cross Country Healthcare (CCRN) Following Investor Day

September 20, 2022 8:27 AM EDT Send to a Friend
Jefferies analyst Brian Tanquilut reiterated a Buy rating and $45.00 price target on Cross Country Healthcare (NASDAQ: CCRN) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login